Targeting the host inflammatory response in traumatic spinal cord injury.
about
The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injuryCytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord InjurySyndromics: a bioinformatics approach for neurotrauma researchIdentifying the Long-Term Role of Inducible Nitric Oxide Synthase after Contusive Spinal Cord Injury Using a Transgenic Mouse Model.An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation.Improved recovery from spinal cord injury in rats with chronic parvovirus serotype-1a infection.Age-dependent transcriptome and proteome following transection of neonatal spinal cord of Monodelphis domestica (South American grey short-tailed opossum)Dantrolene can reduce secondary damage after spinal cord injuryAntiinflammatory activity of melatonin in central nervous systemReduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injuryHybrid equation/agent-based model of ischemia-induced hyperemia and pressure ulcer formation predicts greater propensity to ulcerate in subjects with spinal cord injuryAnti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.Inflammatory mechanisms after ischemia and stroke.P2X receptor-mediated modulation of sensory transmission to the spinal cord dorsal horn.Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.Tumor necrosis factor alpha mediates GABA(A) receptor trafficking to the plasma membrane of spinal cord neurons in vivo.Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects.Setting the stage for functional repair of spinal cord injuries: a cast of thousands.Regeneration following spinal cord injury, from experimental models to humans: where are we?Bone marrow stromal cells for repair of the spinal cord: towards clinical application.Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats.Comparative effects of bone marrow mesenchymal stem cells on lipopolysaccharide-induced microglial activation.Identification of molecular pathway changes after spinal cord injury by microarray analysis.Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia.Netrin-1 Improves Functional Recovery through Autophagy Regulation by Activating the AMPK/mTOR Signaling Pathway in Rats with Spinal Cord Injury.Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.Neurotrophic factors in combinatorial approaches for spinal cord regenerationThe microanatomy of spinal cord injury: a review.Novel targets for Spinal Cord Injury related neuropathic pain.Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease.Transcriptional profiling of spinal cord injury-induced central neuropathic pain.The regenerative effects of electromagnetic field on spinal cord injury.The efficacy of antioxidants in functional recovery of spinal cord injured rats: an experimental study.Metabolic profile of injured human spinal cord determined using surface microdialysis.Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury.Reduced inflammatory cell recruitment and tissue damage in spinal cord injury by acellular spinal cord scaffold seeded with mesenchymal stem cellsMetformin Improves Functional Recovery After Spinal Cord Injury via Autophagy Flux Stimulation.Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in miceEffects of zileuton and montelukast in mouse experimental spinal cord injury.
P2860
Q21089854-6B52E821-C37B-4186-A816-36E20A4345EAQ26740237-0469A70E-3BF5-4621-A0F5-D4112C6B8F5AQ28741573-EFB5CD76-897A-4CED-9FD2-B4910C463E56Q30274915-B97A3D19-8FED-4D29-A9CA-5864E3E172DEQ33464962-1262E913-A89E-4086-9A97-A6FA38DA0AC1Q33586717-17992FD6-5C8E-40AC-83FD-3E462E910759Q33734270-B7A1FC26-3222-4536-A7EF-9D1EF05EA0D2Q33971965-0CE2BE07-B833-4F01-B90C-7CBE9896AAFBQ34402174-D5FE46BC-155C-46F4-8734-C5048CF8DBD7Q34581276-38C5BFC4-B8F6-491C-BBF8-EB2A13EB95B3Q34733535-8360676F-1889-4395-9F98-AF090DC35488Q34827203-09D16A2D-A530-418B-9CAF-B198D7426E21Q35063650-441E5E6D-619D-4BF1-86A2-D014F3CDFDF0Q35568673-C993BF17-471E-48C6-8523-42808AF93100Q35574725-4435975D-62FC-4D68-8EF6-91CD73A7E3CBQ35627073-B48901F0-ED57-4E29-AB70-0C1E142BA23AQ35864331-0F6B3DC2-955B-471A-B9C6-BD773D7D24E6Q35907307-EA1066F9-A4A2-435F-B880-064611FEE5CCQ36020714-6B0A8E6F-0853-4E02-9EF2-ED5903911231Q36481046-B5638770-D074-4203-A826-2CFC3A09B405Q36687134-EDE37F75-AED3-410C-9430-92B61B0866B5Q36731657-3859B516-0DBC-4F8F-AA04-0EEB8CB64DBFQ36755000-E60A086B-4676-453C-BE3B-DB224B1DED6CQ37258195-A8AD66A9-CAA8-4120-A4C8-BDAFBF6DE168Q37543957-D7AC6993-482F-4B5D-940C-50452672D65FQ37635098-BF1AA2FF-7637-4CD8-93ED-0B74C57ED9BCQ37833693-4A9ED459-07D4-4382-9792-7671676D5D0FQ38004819-0A77DD39-6F1D-44D4-99E8-F6B3DBC0D0FFQ38231965-FE185A75-A05C-4E4C-B02A-0E34B1D41F7BQ38247946-94E5F332-DD3F-4F11-B85D-1B814335222DQ38264684-FEEF74FC-1E72-4BB4-A3AB-692BF5AE7955Q38320057-7D29F0AA-1901-4AA2-BC41-F275FA42146DQ38758872-0E5F78A4-0FFD-4FAF-9B8D-5B265DED76B8Q39224701-347AD5E0-73DC-4955-B987-3038EC74602AQ39354554-462E10A4-3353-4AB6-B5CB-2F27D3724987Q41592607-8A67387F-9CCC-4487-8436-7ACDAFDCCA82Q41828545-5729318B-429F-4033-9475-870619EA2D56Q41915116-CE026165-6769-446E-BD63-42DF4BE20708Q42110554-6060B6E9-87A0-4D43-A752-C1900FE596E1Q43042658-40AAC027-CB9F-4B0D-B766-8F989945581D
P2860
Targeting the host inflammatory response in traumatic spinal cord injury.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Targeting the host inflammatory response in traumatic spinal cord injury.
@ast
Targeting the host inflammatory response in traumatic spinal cord injury.
@en
Targeting the host inflammatory response in traumatic spinal cord injury.
@nl
type
label
Targeting the host inflammatory response in traumatic spinal cord injury.
@ast
Targeting the host inflammatory response in traumatic spinal cord injury.
@en
Targeting the host inflammatory response in traumatic spinal cord injury.
@nl
prefLabel
Targeting the host inflammatory response in traumatic spinal cord injury.
@ast
Targeting the host inflammatory response in traumatic spinal cord injury.
@en
Targeting the host inflammatory response in traumatic spinal cord injury.
@nl
P1476
Targeting the host inflammatory response in traumatic spinal cord injury.
@en
P2093
John R Bethea
W Dalton Dietrich
P304
P356
10.1097/00019052-200206000-00021
P577
2002-06-01T00:00:00Z